Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Xenetic Biosciences (XBIO) Operating Expenses (2023 - 2025)

Xenetic Biosciences (XBIO) has disclosed Operating Expenses for 6 consecutive years, with $1.6 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Operating Expenses rose 41.12% year-over-year to $1.6 million, compared with a TTM value of $6.2 million through Sep 2025, down 10.38%, and an annual FY2024 reading of $6.7 million, down 4.97% over the prior year.
  • Operating Expenses was $1.6 million for Q3 2025 at Xenetic Biosciences, up from $1.3 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $2.1 million in Q2 2024 and bottomed at $1.1 million in Q3 2024.
  • Average Operating Expenses over 3 years is $1.7 million, with a median of $1.7 million recorded in 2024.
  • The sharpest move saw Operating Expenses plummeted 36.64% in 2024, then surged 41.12% in 2025.
  • Year by year, Operating Expenses stood at $1.9 million in 2023, then decreased by 9.32% to $1.7 million in 2024, then dropped by 10.08% to $1.6 million in 2025.
  • Business Quant data shows Operating Expenses for XBIO at $1.6 million in Q3 2025, $1.3 million in Q2 2025, and $1.5 million in Q1 2025.